DE60315490D1 - Therapeutische behandlung - Google Patents

Therapeutische behandlung

Info

Publication number
DE60315490D1
DE60315490D1 DE60315490T DE60315490T DE60315490D1 DE 60315490 D1 DE60315490 D1 DE 60315490D1 DE 60315490 T DE60315490 T DE 60315490T DE 60315490 T DE60315490 T DE 60315490T DE 60315490 D1 DE60315490 D1 DE 60315490D1
Authority
DE
Germany
Prior art keywords
therapeutic treatment
therapeutic
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60315490T
Other languages
English (en)
Other versions
DE60315490T2 (de
Inventor
Francis Thomas Boyle
Jon Owen Curwen
Neil James Gallagher
Ursula Joy Hancox
Andrew Mark Hughes
Donna Johnstone
Sian Tomiko Taylor
David William Tonge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE60315490D1 publication Critical patent/DE60315490D1/de
Application granted granted Critical
Publication of DE60315490T2 publication Critical patent/DE60315490T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60315490T 2002-10-12 2003-10-07 Therapeutische behandlung Expired - Lifetime DE60315490T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0223854.1A GB0223854D0 (en) 2002-10-12 2002-10-12 Therapeutic treatment
GB0223854 2002-10-12
PCT/GB2003/004347 WO2004035057A1 (en) 2002-10-12 2003-10-07 Therapeutic treatment

Publications (2)

Publication Number Publication Date
DE60315490D1 true DE60315490D1 (de) 2007-09-20
DE60315490T2 DE60315490T2 (de) 2008-05-08

Family

ID=9945876

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60315490T Expired - Lifetime DE60315490T2 (de) 2002-10-12 2003-10-07 Therapeutische behandlung

Country Status (30)

Country Link
US (1) US20060122180A1 (de)
EP (1) EP1553950B1 (de)
JP (1) JP2006510605A (de)
KR (1) KR20050056238A (de)
CN (1) CN100342853C (de)
AR (1) AR041595A1 (de)
AT (1) ATE369136T1 (de)
AU (1) AU2003269259B2 (de)
BR (1) BR0315140A (de)
CA (1) CA2501959A1 (de)
CY (1) CY1107605T1 (de)
DE (1) DE60315490T2 (de)
DK (1) DK1553950T3 (de)
ES (1) ES2289316T3 (de)
GB (1) GB0223854D0 (de)
HK (1) HK1078784A1 (de)
IS (1) IS2473B (de)
MX (1) MXPA05003808A (de)
MY (1) MY135441A (de)
NO (1) NO20051658L (de)
NZ (1) NZ539137A (de)
PL (1) PL375584A1 (de)
PT (1) PT1553950E (de)
RU (1) RU2005114487A (de)
SA (1) SA04240502B1 (de)
TW (1) TW200412971A (de)
UA (1) UA82492C2 (de)
UY (1) UY28017A1 (de)
WO (1) WO2004035057A1 (de)
ZA (1) ZA200502874B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0218526D0 (en) * 2002-08-09 2002-09-18 Astrazeneca Ab Combination therapy
GB0219660D0 (en) 2002-08-23 2002-10-02 Astrazeneca Ab Therapeutic use
WO2004100991A1 (en) * 2003-05-15 2004-11-25 Universite Catholique De Louvain Use of endothelin-1 antagonists for improving cancer therapy
GB0320806D0 (en) * 2003-09-05 2003-10-08 Astrazeneca Ab Therapeutic treatment
GB0403744D0 (en) 2004-02-20 2004-03-24 Astrazeneca Ab Chemical process
GB0425854D0 (en) * 2004-11-25 2004-12-29 Astrazeneca Ab Therapeutic treatment
DK2209501T3 (da) * 2007-10-12 2012-02-27 Astrazeneca Ab Zibotentan-sammensætning, der indeholder mannitol og mikrokrystallinsk cellulose
EP2464218B1 (de) * 2009-08-10 2015-05-27 Board of Regents, The University of Texas System Behandlung von gehirn metastasen mit einem endothelin rezeptor inhibitor in kombinatio mit einem cytotoxischen chemotherapeutikum
US20220265628A1 (en) * 2019-07-17 2022-08-25 Enb Therapeutics, Inc. Treatment of urothelial and kidney cancers by use of endothelin b receptor antagonists
JPWO2022270487A1 (de) 2021-06-22 2022-12-29

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464853A (en) * 1993-05-20 1995-11-07 Immunopharmaceutics, Inc. N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
GB9300059D0 (en) * 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
UA58494C2 (uk) * 1995-06-07 2003-08-15 Зенека Лімітед Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
TR200003166T2 (tr) * 1998-04-29 2001-02-21 Osi Pharmaceuticals, Inc. N-(3-etinilfenilamino)-6, 7-bis(2-metoksietoksi)-4-kuinozolamin mesilat anhidrat ve monohidrat.
US6355678B1 (en) * 1998-06-29 2002-03-12 Parker Hughes Institute Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
GB0008368D0 (en) * 2000-04-06 2000-05-24 Astrazeneca Ab Combination product
US20020055457A1 (en) * 2000-08-07 2002-05-09 Janus Todd J. Methods of treating cancer and the pain associated therewith using endothelin antagonists
US20030092757A1 (en) * 2001-04-11 2003-05-15 Amitabh Singh Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen

Also Published As

Publication number Publication date
ATE369136T1 (de) 2007-08-15
AR041595A1 (es) 2005-05-26
ES2289316T3 (es) 2008-02-01
NO20051658L (no) 2005-05-06
PT1553950E (pt) 2007-09-26
UA82492C2 (uk) 2008-04-25
AU2003269259B2 (en) 2007-03-15
AU2003269259A1 (en) 2004-05-04
MXPA05003808A (es) 2005-06-08
CY1107605T1 (el) 2013-03-13
SA04240502B1 (ar) 2008-09-14
MY135441A (en) 2008-04-30
EP1553950B1 (de) 2007-08-08
EP1553950A1 (de) 2005-07-20
CA2501959A1 (en) 2004-04-29
PL375584A1 (en) 2005-11-28
CN100342853C (zh) 2007-10-17
NZ539137A (en) 2008-01-31
GB0223854D0 (en) 2002-11-20
US20060122180A1 (en) 2006-06-08
IS2473B (is) 2008-12-15
BR0315140A (pt) 2005-08-16
RU2005114487A (ru) 2006-02-10
DK1553950T3 (da) 2007-10-15
KR20050056238A (ko) 2005-06-14
UY28017A1 (es) 2004-04-30
HK1078784A1 (en) 2006-03-24
ZA200502874B (en) 2006-02-22
TW200412971A (en) 2004-08-01
WO2004035057A1 (en) 2004-04-29
IS7825A (is) 2005-04-26
CN1703224A (zh) 2005-11-30
JP2006510605A (ja) 2006-03-30
DE60315490T2 (de) 2008-05-08

Similar Documents

Publication Publication Date Title
DE60328797D1 (de) Blutbehandlungsgerät
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20052914D0 (no) Terapeutiske forbindelser
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
GB0316912D0 (en) Therapeutic treatment
DE60311298D1 (de) Kopfhautbehandlung
NO20063443L (no) Piperziner effektive for behandling av smerte
GB0320806D0 (en) Therapeutic treatment
IS7825A (is) Meðferðarfræðileg meðhöndlun
NO20050689L (no) Terapeutisk anvendelse
ATE389742T1 (de) Gewebebehandlungsmittel
GB0223367D0 (en) Therapeutic treatment
ATA13602003A (de) Therapeutisches behandlungsgerät
DE60326734D1 (de) Ligations-behandlungsgerät
GB0210464D0 (en) Therapeutic treatment
GB0329275D0 (en) Therapeutic treatment
GB0307863D0 (en) Therapeutic treatment
GB0313772D0 (en) Therapeutic treatment
NO20022747L (no) Behandlingsstol
NO20033160D0 (no) Anordning for behandling av gravann
NO20042850L (no) Kreftbehandling

Legal Events

Date Code Title Description
8364 No opposition during term of opposition